The FDA has approved Exdensur for add-on maintenance treatment of severe asthma characterized by an eosinophilic phenotype in patients aged 12 and older.

Men and women with emphysema benefit from endoscopic lung volume reduction (ELVR), but women may have better symptom response and QoL.

The FDA has approved an oral pellet formulation of Orladeyo® to prevent attacks of hereditary angioedema in pediatric patients.

COVID-19 vaccines given to children last fall helped keep many out of emergency rooms and urgent care, new data shows.

About 9% of patients with inborn errors of immunity/primary immune disorders developed cancer, especially B-NHL, a European study found.

Adult patients with CAP in a low-resource setting who were treated with adjunctive low-dose glucocorticoids had a lower risk of death.

The American Academy of Pediatrics updated its COVID-19 vaccination recommendations for preventing severe disease in children.

The US Food and Drug Administration is considering adding the strongest safety warning available to COVID-19 vaccines.

The 2025 AAO‐HNSF adult sinusitis guideline, an update of the 2015 guideline, offers evidence-based recommendations on rhinosinusitis management.

“The iREACH intervention was effective in improving pediatric clinician adherence to the 2017 PPA guidelines for infants at high and low risk of PA,” the study authors concluded. “Wide dissemination ...

The American Academy of Pediatrics has issued updated recommendations for RSV prevention in infants and high-risk young children.

Federal officials say the FDA is reviewing reports of possible deaths in adults and children following COVID-19 vaccination.